Related Experiment Videos
DSM-III personality disorders in obsessive-compulsive disorder: changes with treatment
M Mavissakalian1, M S Hamann, B Jones
1Department of Psychiatry, Ohio State University, College of Medicine, Columbus 43210.
Comprehensive Psychiatry
|September 1, 1990
Summary
Clomipramine treatment reduced personality disorder diagnoses in obsessive-compulsive disorder (OCD) patients. Personality improvements were greater in treatment responders, but personality factors did not strongly predict OCD treatment outcomes.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Obsessive-compulsive disorder (OCD) is often comorbid with personality disorders (PDs).
- Understanding the impact of OCD treatment on personality functioning is crucial for comprehensive patient care.
Purpose of the Study:
- To investigate the effect of clomipramine treatment on personality variables in patients with OCD.
- To examine whether personality factors predict treatment response in OCD.
Main Methods:
- Twenty-seven OCD patients completed the Personality Diagnostic Questionnaire (PDQ) before and after 12 weeks of clomipramine treatment.
- Patients were assessed for changes in PD diagnoses, trait distribution, and endorsed personality items.
- Treatment responders were compared to non-responders and partial responders regarding personality improvement.
Main Results:
- Clomipramine treatment led to significant reductions in PD diagnoses and associated traits among OCD patients.
- Improvement in personality functioning was more pronounced in patients who responded well to treatment.
- Personality factors did not emerge as strong predictors of overall OCD treatment outcome.
Conclusions:
- Clomipramine therapy can positively impact personality functioning in OCD patients.
- While personality improvements correlate with treatment response, personality traits may not be significant prognostic indicators for OCD treatment success.
- Findings suggest potential parallels and divergences with panic/agoraphobia treatment outcomes.